Gonadal dysfunction in chronic kidney disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Procci WR, Goldstein DA, Adelstein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Intl. 1981;19:317–23.
Toorians AWFT, Janssen E, Laan E, Gooren LJG, Giltay EJ, Oe PL, Donker AJM, Everaerd W. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant. 1997;12:2654–63.
Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser D, Feldman HI. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int. 2001;59:2259–66.
Turk S, Karalezli G, Tonbul HZ, Yildiz M, Altintepe L, Yildiz A, Yeksan M. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001;16:1818–22.
Navaneethan S, Vecchio M, Johnson D, et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis. 2010;56:670–85.
Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012;27:2479–88.
Kaufman JM, Hatzichristou DG, Mulhall JP, Fitch WP, Goldstein I. Impotence and chronic kidney failure: a study of the hemodynamic pathophysiology. J Urol. 1994;151:612–8.
Michal V, Kramar R, Pospichal J. External iliac "steal syndrome. J Cardiovasc Surg. 1978;19:355–7.
Elesber A. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J. 2006;27:824–31.
Campese VM, Procci WR, Levitan D, Romoff MS, Goldstein DA, Massry SG. Autonomic nervous system dysfunction and impotence in uremia. Am J Nephrol. 1982;2:140–3.
Holdsworth SR, de Kretser DM, Atkins RC. A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function. Clin Nephrol. 1978;10:146–50.
Diemont WL, Vruggink PA, Meuleman EJ, Doesburg WH, Lemmens WA, Berden JH. Sexual dysfunction after kidney replacement therapy. Am J Kidney Dis. 2000;35:845–51.
Prem AR, Punekar SV, Kalpana M, Kelkar AR, Acharya VN. Male reproductive function in uraemia: efficacy of haemodialysis and kidney transplantation. Brit. J Urol. 1996;78:635–8.
Guvel S. Calcification of the epididymis and the tunica albuginea of the corpora cavernosa in patients on maintenance hemodialysis. J Androl. 2004;25:752–6.
Bellinghieri G. Ultrastructural changes of corpora cavernosa in men with erectile dysfunction and chronic renal failure. Semin Nephrol. 2004;24:488–91.
Handelsman DJ. Hypothalamic-pituitary gonadal dysfunction in kidney failure, dialysis and kidney transplantation. Endocr Rev. 1985;6:151–82.
Hauser R. Evidence of interaction between polychlorinated biphenyls and phthalates in relation to human sperm motility. Environ Health Perspect. 2005;113:425–30.
De Vries CP, Gooren LJG, Oe PL. Haemodialysis and testicular function. Int J. Andrology. 1984;7:97–103.
Levitan D, Moser SA, Goldstein DA, Kletzky OA, Lobo RA, Massry SG. Disturbances in the hypothalamic-pituitary-gonadal axis in male patients with acute kidney failure. Am J Nephrol. 1984;4:99–106.
Lim VS, Fang VS. Restoration of plasma testosterone levels in uremic men with clomiphene citrate. J Clin Endocrinol Metab. 1976;43:1370–7.
Albaaj F. Prevalence of hypogonadism in male patients with renal failure. Postgrad Med. 2006;82:693–6.
Stewart-Bentley M, Gans D, Horton R. Regulation of gonadal function in uremia. Metabolism. 1974;23:1065–72.
Dunkel L, Raivio T, Laine J, Holmberg C. Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic kidney failure. Kidney Int. 1997;51:777–84.
Cardoso EM, Contreras LN, Tumilasci EG, Elbert A, Aguirre EC, Aquilano DR, Arregger AL. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease. Nephrol Dial Transplant. 2011;26:677–83.
LeRoith D, Danovitz G, Trestian S, Spitz IM. Dissociation of pituitary glycoprotein response to releasing hormones in chronic kidney failure. Acta Endocrinol. 1980;93:277–82.
Schaefer F, Veldhuis JD, Robertson WR, Dunger D. Schärer, the cooperative study group on pubertal development in chronic kidney failure: immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic kidney failure. Kidney Int. 1994;45:1465–76.
Ayub W, Fletcher S. End stage kidney disease and erectile dysfunction. Is there any hope? Nephrol Dial Transplant. 2000;15:1525–8.
Phocas I, Sarandakou A, Rizos D, Kapetanaki A. Serum α-immunoreactive inhibitin in males with kidney failure, under haemodialysis and after successful kidney transplantation. Andrologia. 1995;27:253–8.
Gomez F, de la Cueva R, Wauters J-P, Lemarchand-Beraud T. Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin. Amer. J Med. 1980;68:522–30.
Isaac R, Merceron RE, Caillens G, Raymond J-P, Ardaillou R. Effect of parathyroid hormone on plasma prolactin in man. J Clin Encrinol Metab. 1978;47:18–23.
Massry SG, Goldstein DA, Procci WR, Kletzky OA. Impotence in patients with uremia: a possible role for parathyroid hormone. Nephron. 1997;19:305–10.
Blumberg A, Wildbolz A, Descoeudres C, Hennes U, Dambacher MA, Fischer JA, Weidmann P. Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patients on maintenance hemodialysis. Clin Nephrol. 1980;13:208–14.
Caticha O, Norato DYJ, Tambascia MA, Santana A, Stephanou A, Sarlis NJ. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic kidney insufficiency. J Endocrinol Investig. 1996;19:441–8.
Procci W. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Int. 1981;19:317–23.
Steele TE, Wuerth D, Finkelstein S, Juergensen D, Juergensen P, Kliger AS, Finkelstein FO. Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol. 1996;7:1165–8.
Finkelstein F. Therapy insight:sexual dysfunction in patients with chronic kidney disease. Nature Clin Practice Nephrol. 2007;3:200–7.
Toorians A. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephro. Dial Transplant. 1997;12:2654–63.
Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens. 2001;14:27–31.
Bailie G. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant. 2007;22:1163–7.
Palmer BF. Editorial review: management of sexual dysfunction: responsibility of the primary care physician or the specialist. Advances Kidney Replacement Therapy (Web-only editorial). 1999;6:E4.
Kokot F, Wicek A, Schmidt-Gayk H, Marcinkowski W, Gilge U, Heidland A, Rudka R, Trembecki J. Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Artif Org. 1995;19:428–35.
Schaefer F, van Kaick B, Veldhuis JD, Stein G, Schärer K, Robertson WR, Ritz E. Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. J Am Soc Nephrol. 1994;5:1208–15.
Schaefer RM, Kokot F, Wernze H, Geiger H, Heidland A. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol. 1989;31:1–5.
O'Sullivan DA, McCarthy JT, Kumar R, Williams AW. Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot study. Mayo Clin Proc. 1998;73:1035–45.
McPhatter LL, Lockridge Jr RS, Albert J, Anderson H, Craft V, Jennings FM, Spencer M, Swafford A, Barger T, Coffey L. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther. 1999;6:358–65.
Rendell MS, Rajfer J, Wicker PA, Smith MD. For the sildenafil diabetes study group: sildenafil for treatment of erectile dysfunction in men with diabetes. A randomized controlled trial. J Am Med Assoc. 1999;281:421–6.
Chen J, Mabjeesh NJ, Greenstein A, Nadu A, Matzkin H. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol. 2001;165:819–21.
Rosas SE, Wasserstein A, Kobrin S, Feldman HI. Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients. Am J Kidney Dis. 2001;37:134–7.
Solak Y, Atalay H, Kan S, Kaynar M, Bodur S, Yeksan M, Turk S. Effects of sildenafil and vardenafil treatments on sleep quality and depression in hemodialysis patients with erectile dysfunction. Int J Impot Res. 2011;23:27–31.
Dachille G. Sexual dysfunction in patients under diaytic treatment. Minerva Urol Nefrol. 2006;58:195–200.
Sharma R. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double blind, placebo-controlled, crossover trial. Am J Kidney Dis. 2006;48:128–33.
Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic kidney disease. Kidney Int. 2000;58:1261–6.
Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989;320:1025–30.
Mills TM, Wiedmeier VT, Stopper VS. Androgen maintenance of erectile function in the rat penis. Biol Reprod. 1992;46:342–8.
Bellinghieri G, Santoro D, Lo Forti B, Mallamace A, De Santo RM, Savica V. Erectile dysfunction in uremic dialysis patients: diagnostic evaluation in the sildenafil era. Am J Kidney Dis. 2001;38(4 Suppl 1):S115–7.
Mohamed EA, MacDowall P, Coward RA. Timing of sildenafil therapy in dialysis patients lessons following an episode of hypotension. Nephrol Dial Transplant. 2000;15:926–7.
Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA, McDonald FD. Effect of oral zinc therapy on gonadal function in hemodialysis patients. Ann Intern Med. 1982;97:357–61.
Vecchio M, Navaneethan S, Johnson D, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli G. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010;5:985–95.
Lawrence IG, Price DE, Howlett TA, Harris KPG, Feehally J, Walls J. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kid Dis. 1998;31:313–9.
Pertuz W, Castaneda D, Rincon O, Lozano E. Sexual dysfunction in patients with chronic renal disease: does it improve with renal transplantation? Transplant Proc. 2014;46:3021–6.
Barton CH, Mirahmadi MK, Vaziri ND. Effects of long term testosterone administration on pituitary testicular axis in end stage kidney failure. Nephron. 1982;31:61–4.
van Coevorden A, Stolear JC, Dhaene M, van Herweghem JL, Mockel J. Effect of chronic oral testosterone undecanoate administration on the pituitary testicular axes of hemodialyzed male patients. Clin Nephrol. 1986;26:48–54.
Stein M. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Ds. 1996;28:515–22.
Stehman-Breen C. Racial differences in bone mineral density and bone loss among end-stage renal disease patients. Am J Kidney Dis. 1999;33:941–6.
Palmer B. Outcomes associated with hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Disease. 2004;11:342–7.
Johansen K. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. J Am Med Assoc. 1999;281:1275–81.
Singh A. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. J Clin Endocrinol Metab. 2001;86:2437–45.
Hendler E. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med. 1974;291:1046–51.
Neff MA. Comparison of androgens for anemia in patients on hemodialysis. N Engl J Med. 1981;304:871–5.
Teruel J. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron. 1995;70:282–6.
Gaughan WA. Six month study of low dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis. 1997;30:495–500.
Brockenbrough A. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic kidney disease. Am J Kidney Dis. 2006;47:251–62.
Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:3007–19.
Haring R, Nauck M, Völzke H, Endlich K, Lendeckel U, Friedrich N, Dörr M, Rettig R, Kroemer HK, Wallaschofski H. Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. Am J Nephrol. 2011;33:209–17.
Bello A, Stenvinkel P, Lin M, Hemmelgarn B, Thadhani R, Klarenbach S, Chan C, Zimmerman D, Cembrowski G, Strippoli G, Carrero J, Tonelli M. Serum testosterone levels and clinical outcomes in male hemodialysis patients. Am J Kidney Dis. 2014;63:268–75.
Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV Jr, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis 2014;64:367–374
Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:1617–25.
Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kid Dis. 1997;29:685–90.
Ginsburg ES, Owen Jr WF. Reproductive endocrinology and pregnancy in women on hemodialysis. Sem Dial. 1993;6:105–16.
Peng Y. Sexual dysfunction in female hemodialysis patients: a multicenter study. Kidney Int. 2005;68:760–5.
Barua M, Hladunewich M, Keunen J, Pierratos A, McFarlane P, Sood M, Chan C. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2008;3:392–6.
Hou S. Pregnancy in chronic kidney insufficiency and end-stage kidney disease. Am J Kidney Ds. 1999;33:235–52.
Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic kidney failure: evidence suggesting hypothalamic anovulation. Ann Intern Med. 1980;93:21–7.
Zingraff J, Jungers P, Pélissier C, Nahoul K, Feinstein MC, Scholler R. Pituitary and ovarian dysfunctions in women on haemodialysis. Nephron. 1982;30:149–53.
Mor M, Sevick M, Shields A, Green J, Palevsky P, Arnold R, Fine M, Weisbord S. Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol. 2014;9:128–34.
Strippoli G. For the collaborative depression and sexual dysfunction (CDS) in hemodialysis working group. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012;7:974–81.
Simon J. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90:5226–33.
Weisinger JR, Gonzalez L, Alvarez H, Hernandez E, Carlini RG, Capriles F, Cervino M, Martinis R, Paz Martinez V, Bellorin Font E. Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women. Kidney Int. 2000;58:331–5.
Cochrane R, Regan L. Undetected gynaecological disorders in women with kidney disease. Hum Reprod. 1997;12:667–70.
Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis. 1997;29:685–90.